Hookipa Pharma Inc (NASDAQ: HOOK) on November 20, 2023, started off the session at the price of $0.54, plunging -2.31% from the previous trading day. During the day, the shares moved up to $0.55 and dropped to $0.4705 before settling in for the closing price of $0.52. Within the past 52 weeks, HOOK’s price has moved between $0.41 and $2.05.
During the last 5-year period, the sales growth of Healthcare Sector giant was 18.39%. The company achieved an average annual earnings per share of 12.46%. With a float of $74.37 million, this company’s outstanding shares have now reached $83.95 million.
Let’s determine the extent of company efficiency that accounts for 156 employees. In terms of profitability, gross margin is +74.72, operating margin of -513.40, and the pretax margin is -453.96.
Hookipa Pharma Inc (HOOK) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Hookipa Pharma Inc is 11.42%, while institutional ownership is 49.50%. The most recent insider transaction that took place on Aug 21, was worth 5,075. In this transaction Chief Financial Officer of this company bought 7,000 shares at a rate of $0.72, taking the stock ownership to the 43,092 shares. Before that another transaction happened on Aug 16, when Company’s Chief Financial Officer bought 8,000 for $0.71, making the entire transaction worth $5,712. This insider now owns 36,092 shares in total.
Hookipa Pharma Inc (HOOK) Recent Fiscal highlights
As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.17 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.21) by $0.04. This company achieved a net margin of -455.58 while generating a return on equity of -67.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.46% per share during the next fiscal year.
Hookipa Pharma Inc (NASDAQ: HOOK) Trading Performance Indicators
Hookipa Pharma Inc (HOOK) is currently performing well based on its current performance indicators. A quick ratio of 3.44 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Hookipa Pharma Inc (HOOK)
Looking closely at Hookipa Pharma Inc (NASDAQ: HOOK), its last 5-days average volume was 1.2 million, which is a jump from its year-to-date volume of 0.65 million. As of the previous 9 days, the stock’s Stochastic %D was 63.85%. Additionally, its Average True Range was 0.05.
During the past 100 days, Hookipa Pharma Inc’s (HOOK) raw stochastic average was set at 18.65%, which indicates a significant decrease from 69.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.43% in the past 14 days, which was higher than the 62.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5349, while its 200-day Moving Average is $0.8321. However, in the short run, Hookipa Pharma Inc’s stock first resistance to watch stands at $0.5478. Second resistance stands at $0.5887. The third major resistance level sits at $0.6273. If the price goes on to break the first support level at $0.4683, it is likely to go to the next support level at $0.4297. Now, if the price goes above the second support level, the third support stands at $0.3888.
Hookipa Pharma Inc (NASDAQ: HOOK) Key Stats
Market capitalization of the company is 42.56 million based on 83,950K outstanding shares. Right now, sales total 14,250 K and income totals -64,920 K. The company made 6,870 K in profit during its latest quarter, and -19,070 K in sales during its previous quarter.